Home › Funds › Nantahala Capital Management, LLC › SVRA
Nantahala Capital Management, LLC position in SVRA
SAVARA INC · Health Care
Nantahala Capital Management, LLC reported holding 7,137,159 shares of SVRA (SAVARA INC) in its Q3 2026 13F filing — a position valued at US$36.8M, representing 1.69% of its reported portfolio and ranking #13 among its reported holdings. Nantahala Capital Management, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's SVRA position evolved
Nantahala Capital Management, LLC first disclosed a stake in SVRA in Q3 2023 at 1,039,364 shares (US$3.9M). The position peaked in Q4 2025 at 7,344,783 shares, worth US$44.3M. Across 13 filings, Nantahala Capital Management, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,137,159 shares valued at US$36.8M — an increase of 160,349 shares quarter over quarter.. Notable position changes include a 76% increase in Q1 2024 (shares fell 19% over the following quarter), a 198% increase in Q2 2024 (shares rose 5% over the following quarter), a 45% increase in Q4 2024 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.04M | $3.93M | New |
| Q4 2023 | 987.90K | $4.64M | Reduce |
| Q1 2024 | 1.74M | $8.65M | Add |
| Q2 2024 | 5.18M | $20.88M | Add |
| Q3 2024 | 5.18M | $21.97M | Hold |
| Q4 2024 | 7.53M | $23.10M | Add |
| Q1 2025 | 8.08M | $22.37M | Add |
| Q2 2025 | 8.33M | $18.98M | Add |
| Q3 2025 | 8.78M | $31.33M | Add |
| Q4 2025 | 7.34M | $44.29M | Reduce |
| Q1 2026 | 7.34M | $40.10M | Hold |
| Q2 2026 | 6.98M | $42.98M | Reduce |
| Q3 2026 | 7.14M | $36.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SVRA and 13F data
SVRA (SAVARA INC) is a Health Care company. 40 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SVRA
- NEA Management Company, LLC 24.47M sh · $150.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 17.60M sh · $108.42M · Q2 2026
- Venrock Adviser, LLC 14.75M sh · $90.84M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 13.57M sh · $83.59M · Q2 2026
- TCG Crossover Management, LLC 12.36M sh · $76.15M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.72M sh · $59.88M · Q2 2026
- Spruce Street Capital LP 5.38M sh · $27.77M · Q3 2026
- Rosalind Advisors, Inc. 3.18M sh · $19.58M · Q2 2026
- Vestal Point Capital, LP 2.72M sh · $16.76M · Q2 2026
- Affinity Asset Advisors, LLC 2.51M sh · $12.96M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 1.84M sh · $9.51M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.52M sh · $7.84M · Q3 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held SVRA?
Nantahala Capital Management, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nantahala Capital Management, LLC's current position in SVRA?
As of Q3 2026, Nantahala Capital Management, LLC holds 7.14M shares of SVRA (SAVARA INC), valued at $36.83M, representing 1.69% of its reported portfolio and ranking #13.
Has Nantahala Capital Management, LLC been buying or selling SVRA?
In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in SVRA. The position peaked in Q4 2025 at 7.34M shares.
Which other funds hold SVRA?
Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.